The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 09, 2017

Filed:

Aug. 18, 2014
Applicants:

Jianfeng Cai, Tampa, FL (US);

Chuanhai Cao, Temple Terrace, FL (US);

Haifan Wu, Tampa, FL (US);

Yaqiong LI, Tampa, FL (US);

GE Bai, Tampa, FL (US);

Inventors:

Jianfeng Cai, Tampa, FL (US);

Chuanhai Cao, Temple Terrace, FL (US);

Haifan Wu, Tampa, FL (US);

Yaqiong Li, Tampa, FL (US);

Ge Bai, Tampa, FL (US);

Assignee:

UNIVERSITY OF SOUTH FLORIDA, Tampa, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C40B 50/14 (2006.01); G01N 33/68 (2006.01); A61K 51/04 (2006.01); C07C 271/22 (2006.01); C07K 14/47 (2006.01); B01J 19/00 (2006.01); C07K 5/02 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6845 (2013.01); A61K 51/0406 (2013.01); B01J 19/0046 (2013.01); C07C 271/22 (2013.01); C07K 5/02 (2013.01); C07K 14/4711 (2013.01); G01N 33/6896 (2013.01); A61K 38/00 (2013.01); B01J 2219/00592 (2013.01); B01J 2219/00596 (2013.01); B01J 2219/00725 (2013.01); C07C 2103/18 (2013.01); G01N 2333/4709 (2013.01); G01N 2500/04 (2013.01); G01N 2500/20 (2013.01); G01N 2800/2821 (2013.01);
Abstract

Embodiments of the present disclosure provide for γ-AApeptides, γ-AApeptide building blocks, methods of making γ-AApeptides and libraries of γ-AApeptides, methods of screening the γ-AApeptide libraries for desired peptidomimetic activity, and the like. The present disclosure also provides for γ-AApeptides that are inhibitors of Aβ peptide aggregation, methods of inhibiting and disassembling Aβ peptide aggregation, methods of inhibiting the toxicity of Aβ aggregates towards N2a neuroblasotma cells, as well as methods and compounds for treating Alzheimer's disease.


Find Patent Forward Citations

Loading…